Activist investor pushes for management overhaul, strategic review at Theravance
In a letter to Theravance Biopharma Monday morning, activist investor Irenic Capital Management pushed for significant changes to the board, a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
